Impact of the Addition of Beta-Hydroxybutyrate in the 72-Hour Fast Protocol on Hospitalization Duration: A Quality Improvement Report
Adding a BHB >2.7 mmol/L stopping criterion reduced inpatient hospitalization time, medical costs, and patient burden without compromising insulinoma detection. This evidence-based intervention improves patient adherence and more effectively uses hospital resources.
Authors
- Vinni Makin (ORCID: https://orcid.org/0000-0003-1622-153X)
- Michelle D. Lundholm (ORCID: https://orcid.org/0000-0002-7137-1365)
- Dianna Jo Copley
- Pratibha PR Rao
Institutions
- Cleveland Clinic (US)
- Center for Practical Bioethics (US)
- Center for Clinical Research (United States) (US)
Publication Details
- Journal
- Endocrine Practice
- Published
- 2025-04-25
- DOI
- https://doi.org/10.1016/j.eprac.2025.04.015
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00